MEDICAL UNIVERSITY OF VIENNA

meduniwienlogo_2-1746.png
 

Optical Coherence Tomography (OCT) was originally developed at the Centre of Medical Physics and Biomedical Engineering (CMPBME) at the MUW and the Massachusetts Institute of Technology (Cambridge, MA, USA) in the early 1990s, and the MUW is still a leader and pioneer in the development of state-of-the-art OCT technology. Current and previous members of this Centre, leading in Europe and the second-best scientific OCT output worldwide, have published more than 3% of all OCT publications (around 6000). CMPBME has successfully coordinated and participated in several national and international (especially ERC funded) projects. In carrying out these duties, CMPBME will successfully be assisted by competent administrative staff members from MUW.

Contribution to the project

MUW will be leading WP3 and WP7 of the project and is developing the OCT system. Furthermore, MUW is responsible for the integration of all imaging modalities. Due to its door-to-door collaboration with the clinics at the General Hospital of Vienna, the largest hospital in Austria, it will be perform the clinical validation of the fully functional multimodal imaging platform in WP7. MUW is further contributing to the development of the probe head development in WP5 and its integration in WP6

Key persons

Prof. Rainer Leitgeb has expertise in functional Optical Coherence Tomography, Coherence Microscopy, Parallel OCT, Digital Refocusing and management expertise as coordinator of and work package leader within national and EC research projects, and as head of laboratory. He is the director of Christian Doppler Laboratory of Innovative Optical Imaging and its Translation to Medicine, coordinating EC ICT MOON and is/has participating/ed in EC projects: MIB (H2020) FBI (H2020), ESOTRAC (H2020), FUN OCT (FP7);

Research Record:

  • More than 150 publications, h-index: 51 (GScholar)

  • More than 10000 citations

  • Co-Editor of 2 books

  • More than 70 invited or keynote talks since 2000

  • About € 5 million research grant income since 2004

  • 2007 ARVO/Alcon Early Career Clinician Scientist Research Award

  • 2007 ZEISS MEDITEC award as recognition for contributions to new retinal OCT generation

  • 2014/2016 elected SPIE Fellow / elected OSA Fellow

Prof. Angelika Unterhuber has expertise in ultrafast laser physics as product developer and manager (Femtolasers), Optical Coherence Tomography, and nonlinear optical microscopy including Raman techniques. She has participated in several EC projects: FUN OCT (FP7), 3D3CSI (FP7-PEOPLE.2009-IEF), FAMOS (FP7), OCTCHIP (FP7), MIB (H2020), FBI (H2020)

Research Record:

  • Author and co-author of 64 articles in peer-reviewed journals, , h-index: 33 (Scopus)

  • Contributions to 4 book chapters in edited books,

  • More than 20 oral/poster presentations (4 invited talks)

  • More than 130 conference contributions

University Assistant Marco Andreana (male) has expertise in nonlinear optical microscopy, OCT and Raman techniques. He is Univ. Ass. at the Center for Medical Physics and Biomedical Engineering, General Hospital Vienna, Medical University of Vienna, Austria and has participated in EC projects: FAMOS (FP7), MIB (H2020), FBI (H2020).

Research Record:

  • Author and co-author of 27 articles in peer-reviewed journals, , h-index: 33 (Scopus)

  • More than 15 oral/poster presentations (2 invited talks)

  • More than 50 conference contributions

Prof. Werner Dolak is Full Professor of Medical Physics and Head of Center for Biomedical Engineering and Physics and will support the project with his OCT expertise. He coordinated EC IP FAMOS and ICT OCTCHIP and is/has participating/ed in EC projects: MOON (H2020), MIB (H2020) FBI (H2020), ESOTRAC (H2020), BIOPSYPEN (FP7); FUN OCT (FP7); 3D3CSI (FP7-PEOPLE.2009-IEF); NANO UB SOURCES (FP6); UR-OCT (FP5).

Research Record:

  • More than 200 publications in peer reviewed journals, h-index: 69 (Scopus)

  • More than 20000 citations

  • (Co)Editor of 15 books

  • About 250 invited or keynote talks since 2000

  • More than € 16 million research grant income since 2000